Skip to main content
Fig. 7 | Journal of Hematology & Oncology

Fig. 7

From: The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells

Fig. 7

LRRC4 inhibits ERK-mediated activation of the downstream substrates to inhibit U251 cell proliferation via the D domain. a U251 cells were transfected with vector, LRRC4 or LRRC4-ΔD plasmid. Western blot showing the phosphorylation level of the ERK downstream substrates ELK1, FOXO3a, and CDC25a. b U251 cells were transfected with vector, LRRC4, or LRRC4-ΔD plasmids and were then subjected to CCK8 assays for the indicated times. *LRRC4 vs vector, #LRRC4-ΔD vs vector. *** p < 0.001; ## p < 0.01; ### p < 0.001. c U251 cells were transfected with vector, LRRC4, or LRRC4-ΔD plasmid. Matrigel chamber invasion assay showing the invasion of U251 cells. The data represent the mean±SD of three replicates. Bar in the graph represents the s.e.m. One-way ANOVA, * p < 0.05; ** p < 0.01; *** p < 0.001; ## p < 0.01; ### p < 0.001

Back to article page